Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB25FZC75
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $41,659
Award facts
- Contract value 100% obligated
- $41,658.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $41,658.60 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on September 10, 2025, for the supply of Nexplanon 68 mg implants, with an ultimate completion date of October 1, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order falls under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with DLA valued at $499,999,999 and valid through November 2026, specifically under the SPE2DB program, which authorizes firm fixed-price delivery orders for pharmaceutical supplies supporting military health facilities nationwide.
This delivery order represents a tactical replenishment of contraceptive devices within DLA's broader pharmaceutical supply chain operations supporting Department of Defense healthcare systems. DMS Pharmaceutical Group has established itself as a critical supplier through consistent contract performance delivering an extensive portfolio of pharmaceutical products, including prescription medications, biologics, and medical consumables. The company's federal procurement success demonstrates effective competition in open markets leveraging its woman-owned small business status while maintaining robust capability to fulfill time-sensitive pharmaceutical delivery requirements for military medical facilities.
Quick answers
Who was awarded contract SPE2DB25FZC75?
SPE2DB25FZC75 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 10, 2025.
How much is contract SPE2DB25FZC75 worth?
The government has obligated $41,659 on SPE2DB25FZC75.
Is contract SPE2DB25FZC75 an order under another contract?
Yes. SPE2DB25FZC75 is a delivery order under SPE2DB22D9143, an indefinite delivery contract.
Was contract SPE2DB25FZC75 competed?
The extent of competition for SPE2DB25FZC75 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award